<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-02-01" modified="2020-10-07" version="193">
<accession>P33778</accession>
<accession>Q4KN36</accession>
<name>H2B1B_HUMAN</name>
<protein>
<recommendedName>
<fullName>Histone H2B type 1-B</fullName>
</recommendedName>
<alternativeName>
<fullName evidence="24">H2B-clustered histone 3</fullName>
</alternativeName>
<alternativeName>
<fullName>Histone H2B.1</fullName>
</alternativeName>
<alternativeName>
<fullName>Histone H2B.f</fullName>
<shortName>H2B/f</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="24">H2BC3</name>
<name type="synonym">H2BFF</name>
<name type="synonym" evidence="24">HIST1H2BB</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Genomics" volume="10" first="940" last="948">
<title>Isolation and characterization of two human H1 histone genes within clusters of core histone genes.</title>
<authorList>
<person name="Albig W."/>
<person name="Kardalinou E."/>
<person name="Drabent B."/>
<person name="Zimmer A."/>
<person name="Doenecke D."/>
</authorList>
<dbReference type="PubMed" id="1916825"/>
<dbReference type="DOI" id="10.1016/0888-7543(91)90183-f"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2002" name="Genomics" volume="80" first="487" last="498">
<title>The human and mouse replication-dependent histone genes.</title>
<authorList>
<person name="Marzluff W.F."/>
<person name="Gongidi P."/>
<person name="Woods K.R."/>
<person name="Jin J."/>
<person name="Maltais L.J."/>
</authorList>
<dbReference type="PubMed" id="12408966"/>
<dbReference type="DOI" id="10.1006/geno.2002.6850"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="2579" last="2588">
<title>Global regulation of post-translational modifications on core histones.</title>
<authorList>
<person name="Galasinski S.C."/>
<person name="Louie D.F."/>
<person name="Gloor K.K."/>
<person name="Resing K.A."/>
<person name="Ahn N.G."/>
</authorList>
<dbReference type="PubMed" id="11709551"/>
<dbReference type="DOI" id="10.1074/jbc.m107894200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>METHYLATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="Cell" volume="113" first="507" last="517">
<title>Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase.</title>
<authorList>
<person name="Cheung W.L."/>
<person name="Ajiro K."/>
<person name="Samejima K."/>
<person name="Kloc M."/>
<person name="Cheung P."/>
<person name="Mizzen C.A."/>
<person name="Beeser A."/>
<person name="Etkin L.D."/>
<person name="Chernoff J."/>
<person name="Earnshaw W.C."/>
<person name="Allis C.D."/>
</authorList>
<dbReference type="PubMed" id="12757711"/>
<dbReference type="DOI" id="10.1016/s0092-8674(03)00355-6"/>
</citation>
<scope>PHOSPHORYLATION AT SER-15</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2005" name="Mol. Cell" volume="20" first="601" last="611">
<title>Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation.</title>
<authorList>
<person name="Zhu B."/>
<person name="Zheng Y."/>
<person name="Pham A.-D."/>
<person name="Mandal S.S."/>
<person name="Erdjument-Bromage H."/>
<person name="Tempst P."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="16307923"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.09.025"/>
</citation>
<scope>UBIQUITINATION AT LYS-121</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2005" name="Mol. Cell. Biochem." volume="279" first="133" last="139">
<title>Inhibition of core histones acetylation by carcinogenic nickel(II).</title>
<authorList>
<person name="Golebiowski F."/>
<person name="Kasprzak K.S."/>
</authorList>
<dbReference type="PubMed" id="16283522"/>
<dbReference type="DOI" id="10.1007/s11010-005-8285-1"/>
</citation>
<scope>ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Cell" volume="125" first="703" last="717">
<title>Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II.</title>
<authorList>
<person name="Pavri R."/>
<person name="Zhu B."/>
<person name="Li G."/>
<person name="Trojer P."/>
<person name="Mandal S."/>
<person name="Shilatifard A."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="16713563"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.04.029"/>
</citation>
<scope>UBIQUITINATION AT LYS-121</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-13; LYS-16; LYS-17; LYS-21 AND LYS-24</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2011" name="Cell" volume="146" first="1016" last="1028">
<title>Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification.</title>
<authorList>
<person name="Tan M."/>
<person name="Luo H."/>
<person name="Lee S."/>
<person name="Jin F."/>
<person name="Yang J.S."/>
<person name="Montellier E."/>
<person name="Buchou T."/>
<person name="Cheng Z."/>
<person name="Rousseaux S."/>
<person name="Rajagopal N."/>
<person name="Lu Z."/>
<person name="Ye Z."/>
<person name="Zhu Q."/>
<person name="Wysocka J."/>
<person name="Ye Y."/>
<person name="Khochbin S."/>
<person name="Ren B."/>
<person name="Zhao Y."/>
</authorList>
<dbReference type="PubMed" id="21925322"/>
<dbReference type="DOI" id="10.1016/j.cell.2011.08.008"/>
</citation>
<scope>CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND LYS-35</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2011" name="Mol. Cell" volume="43" first="132" last="144">
<title>The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation.</title>
<authorList>
<person name="Wu L."/>
<person name="Zee B.M."/>
<person name="Wang Y."/>
<person name="Garcia B.A."/>
<person name="Dou Y."/>
</authorList>
<dbReference type="PubMed" id="21726816"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.05.015"/>
</citation>
<scope>UBIQUITINATION AT LYS-35</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="100" last="107">
<title>Lysine succinylation and lysine malonylation in histones.</title>
<authorList>
<person name="Xie Z."/>
<person name="Dai J."/>
<person name="Dai L."/>
<person name="Tan M."/>
<person name="Cheng Z."/>
<person name="Wu Y."/>
<person name="Boeke J.D."/>
<person name="Zhao Y."/>
</authorList>
<dbReference type="PubMed" id="22389435"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015875"/>
</citation>
<scope>SUCCINYLATION AT LYS-35; LYS-117 AND LYS-121</scope>
<scope>MALONYLATION AT LYS-117</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2013" name="Genes Dev." volume="27" first="1581" last="1595">
<title>USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA splicing.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Jones A."/>
<person name="Joo H.Y."/>
<person name="Zhou D."/>
<person name="Cao Y."/>
<person name="Chen S."/>
<person name="Erdjument-Bromage H."/>
<person name="Renfrow M."/>
<person name="He H."/>
<person name="Tempst P."/>
<person name="Townes T.M."/>
<person name="Giles K.E."/>
<person name="Ma L."/>
<person name="Wang H."/>
</authorList>
<dbReference type="PubMed" id="23824326"/>
<dbReference type="DOI" id="10.1101/gad.211037.112"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP49</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2014" name="Nat. Chem. Biol." volume="10" first="365" last="370">
<title>Lysine 2-hydroxyisobutyrylation is a widely distributed active histone mark.</title>
<authorList>
<person name="Dai L."/>
<person name="Peng C."/>
<person name="Montellier E."/>
<person name="Lu Z."/>
<person name="Chen Y."/>
<person name="Ishii H."/>
<person name="Debernardi A."/>
<person name="Buchou T."/>
<person name="Rousseaux S."/>
<person name="Jin F."/>
<person name="Sabari B.R."/>
<person name="Deng Z."/>
<person name="Allis C.D."/>
<person name="Ren B."/>
<person name="Khochbin S."/>
<person name="Zhao Y."/>
</authorList>
<dbReference type="PubMed" id="24681537"/>
<dbReference type="DOI" id="10.1038/nchembio.1497"/>
</citation>
<scope>HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35; LYS-44; LYS-47; LYS-58; LYS-86; LYS-109; LYS-117 AND LYS-121</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2016" name="Mol. Cell" volume="62" first="169" last="180">
<title>Dynamic competing histone H4 K5K8 acetylation and butyrylation are hallmarks of highly active gene promoters.</title>
<authorList>
<person name="Goudarzi A."/>
<person name="Zhang D."/>
<person name="Huang H."/>
<person name="Barral S."/>
<person name="Kwon O.K."/>
<person name="Qi S."/>
<person name="Tang Z."/>
<person name="Buchou T."/>
<person name="Vitte A.L."/>
<person name="He T."/>
<person name="Cheng Z."/>
<person name="Montellier E."/>
<person name="Gaucher J."/>
<person name="Curtet S."/>
<person name="Debernardi A."/>
<person name="Charbonnier G."/>
<person name="Puthier D."/>
<person name="Petosa C."/>
<person name="Panne D."/>
<person name="Rousseaux S."/>
<person name="Roeder R.G."/>
<person name="Zhao Y."/>
<person name="Khochbin S."/>
</authorList>
<dbReference type="PubMed" id="27105113"/>
<dbReference type="DOI" id="10.1016/j.molcel.2016.03.014"/>
</citation>
<scope>BUTYRYLATION AT LYS-6 AND LYS-21</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2016" name="Mol. Cell" volume="62" first="194" last="206">
<title>Metabolic regulation of gene expression by histone lysine beta-hydroxybutyrylation.</title>
<authorList>
<person name="Xie Z."/>
<person name="Zhang D."/>
<person name="Chung D."/>
<person name="Tang Z."/>
<person name="Huang H."/>
<person name="Dai L."/>
<person name="Qi S."/>
<person name="Li J."/>
<person name="Colak G."/>
<person name="Chen Y."/>
<person name="Xia C."/>
<person name="Peng C."/>
<person name="Ruan H."/>
<person name="Kirkey M."/>
<person name="Wang D."/>
<person name="Jensen L.M."/>
<person name="Kwon O.K."/>
<person name="Lee S."/>
<person name="Pletcher S.D."/>
<person name="Tan M."/>
<person name="Lombard D.B."/>
<person name="White K.P."/>
<person name="Zhao H."/>
<person name="Li J."/>
<person name="Roeder R.G."/>
<person name="Yang X."/>
<person name="Zhao Y."/>
</authorList>
<dbReference type="PubMed" id="27105115"/>
<dbReference type="DOI" id="10.1016/j.molcel.2016.03.036"/>
</citation>
<scope>HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-17; LYS-21; LYS-35; LYS-86; LYS-117 AND LYS-121</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2019" name="Mol. Cell">
<title>Glutarylation of histone H4 lysine 91 regulates chromatin dynamics.</title>
<authorList>
<person name="Bao X."/>
<person name="Liu Z."/>
<person name="Zhang W."/>
<person name="Gladysz K."/>
<person name="Fung Y.M.E."/>
<person name="Tian G."/>
<person name="Xiong Y."/>
<person name="Wong J.W.H."/>
<person name="Yuen K.W.Y."/>
<person name="Li X.D."/>
</authorList>
<dbReference type="PubMed" id="31542297"/>
<dbReference type="DOI" id="10.1016/j.molcel.2019.08.018"/>
</citation>
<scope>GLUTARYLATION AT LYS-17; LYS-35; LYS-44; LYS-47; LYS-109; LYS-117 AND LYS-121</scope>
</reference>
<comment type="function">
<text>Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.</text>
</comment>
<comment type="subunit">
<text>The nucleosome is a histone octamer containing two molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of DNA.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-357986">
<id>P33778</id>
</interactant>
<interactant intactId="EBI-17589229">
<id>Q6NTF9-3</id>
<label>RHBDD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Chromosome</location>
</subcellularLocation>
</comment>
<comment type="PTM">
<text evidence="11">Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is required for histone H3 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me) methylation and transcription activation at specific gene loci, such as HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121 (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 'Lys-4' and 'Lys-79' methylation. It also functions cooperatively with the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub also acts as a regulator of mRNA splicing: deubiquitination by USP49 is required for efficient cotranscriptional splicing of a large set of exons.</text>
</comment>
<comment type="PTM">
<text evidence="9 11 12">Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress promotes transcription (By similarity). Phosphorylated on Ser-15 (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic chromatin condensation. Also phosphorylated on Ser-15 in response to DNA double strand breaks (DSBs), and in correlation with somatic hypermutation and immunoglobulin class-switch recombination.</text>
</comment>
<comment type="PTM">
<text evidence="6">GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121. It fluctuates in response to extracellular glucose, and associates with transcribed genes (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="17">Crotonylation (Kcr) is specifically present in male germ cells and marks testis-specific genes in post-meiotic cells, including X-linked genes that escape sex chromosome inactivation in haploid cells. Crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors. It is also associated with post-meiotically activated genes on autosomes.</text>
</comment>
<comment type="similarity">
<text evidence="23">Belongs to the histone H2B family.</text>
</comment>
<dbReference type="EMBL" id="X57127">
<property type="protein sequence ID" value="CAA40406.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF531285">
<property type="protein sequence ID" value="AAN06685.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC096728">
<property type="protein sequence ID" value="AAH96728.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4575.1"/>
<dbReference type="PIR" id="I37445">
<property type="entry name" value="I37445"/>
</dbReference>
<dbReference type="RefSeq" id="NP_066406.1">
<property type="nucleotide sequence ID" value="NM_021062.2"/>
</dbReference>
<dbReference type="PDB" id="3X1S">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.81"/>
<property type="chains" value="D/H=2-126"/>
</dbReference>
<dbReference type="PDB" id="3X1U">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="D/H=3-126"/>
</dbReference>
<dbReference type="PDBsum" id="3X1S"/>
<dbReference type="PDBsum" id="3X1U"/>
<dbReference type="SMR" id="P33778"/>
<dbReference type="BioGRID" id="109271">
<property type="interactions" value="319"/>
</dbReference>
<dbReference type="CORUM" id="P33778"/>
<dbReference type="DIP" id="DIP-47505N"/>
<dbReference type="IntAct" id="P33778">
<property type="interactions" value="18"/>
</dbReference>
<dbReference type="MINT" id="P33778"/>
<dbReference type="STRING" id="9606.ENSP00000482674"/>
<dbReference type="GlyGen" id="P33778">
<property type="glycosylation" value="2 sites, 1 O-linked glycan (1 site)"/>
</dbReference>
<dbReference type="iPTMnet" id="P33778"/>
<dbReference type="MetOSite" id="P33778"/>
<dbReference type="PhosphoSitePlus" id="P33778"/>
<dbReference type="SwissPalm" id="P33778"/>
<dbReference type="BioMuta" id="HIST1H2BB"/>
<dbReference type="DMDM" id="462236"/>
<dbReference type="jPOST" id="P33778"/>
<dbReference type="MassIVE" id="P33778"/>
<dbReference type="MaxQB" id="P33778"/>
<dbReference type="PaxDb" id="P33778"/>
<dbReference type="PeptideAtlas" id="P33778"/>
<dbReference type="PRIDE" id="P33778"/>
<dbReference type="ProteomicsDB" id="54927"/>
<dbReference type="TopDownProteomics" id="P33778"/>
<dbReference type="Antibodypedia" id="72531">
<property type="antibodies" value="244 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="3018"/>
<dbReference type="Ensembl" id="ENST00000615966">
<property type="protein sequence ID" value="ENSP00000482674"/>
<property type="gene ID" value="ENSG00000276410"/>
</dbReference>
<dbReference type="GeneID" id="3018"/>
<dbReference type="KEGG" id="hsa:3018"/>
<dbReference type="UCSC" id="uc003nfu.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3018"/>
<dbReference type="DisGeNET" id="3018"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000276410.2"/>
<dbReference type="GeneCards" id="H2BC3"/>
<dbReference type="HGNC" id="HGNC:4751">
<property type="gene designation" value="H2BC3"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000276410">
<property type="expression patterns" value="Tissue enriched (lymphoid)"/>
</dbReference>
<dbReference type="MIM" id="602803">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P33778"/>
<dbReference type="OpenTargets" id="ENSG00000276410"/>
<dbReference type="PharmGKB" id="PA29126"/>
<dbReference type="eggNOG" id="KOG1744">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214389"/>
<dbReference type="InParanoid" id="P33778"/>
<dbReference type="KO" id="K11252"/>
<dbReference type="OMA" id="FETKSAP"/>
<dbReference type="OrthoDB" id="1536672at2759"/>
<dbReference type="PhylomeDB" id="P33778"/>
<dbReference type="TreeFam" id="TF300212"/>
<dbReference type="PathwayCommons" id="P33778"/>
<dbReference type="Reactome" id="R-HSA-110328">
<property type="pathway name" value="Recognition and association of DNA glycosylase with site containing an affected pyrimidine"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-110329">
<property type="pathway name" value="Cleavage of the damaged pyrimidine"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-110330">
<property type="pathway name" value="Recognition and association of DNA glycosylase with site containing an affected purine"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-110331">
<property type="pathway name" value="Cleavage of the damaged purine"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1221632">
<property type="pathway name" value="Meiotic synapsis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-171306">
<property type="pathway name" value="Packaging Of Telomere Ends"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1912408">
<property type="pathway name" value="Pre-NOTCH Transcription and Translation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-201722">
<property type="pathway name" value="Formation of the beta-catenin:TCF transactivating complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-212300">
<property type="pathway name" value="PRC2 methylates histones and DNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2299718">
<property type="pathway name" value="Condensation of Prophase Chromosomes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559580">
<property type="pathway name" value="Oxidative Stress Induced Senescence"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559582">
<property type="pathway name" value="Senescence-Associated Secretory Phenotype (SASP)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559586">
<property type="pathway name" value="DNA Damage/Telomere Stress Induced Senescence"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3214815">
<property type="pathway name" value="HDACs deacetylate histones"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3214847">
<property type="pathway name" value="HATs acetylate histones"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-427359">
<property type="pathway name" value="SIRT1 negatively regulates rRNA expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-427389">
<property type="pathway name" value="ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-427413">
<property type="pathway name" value="NoRC negatively regulates rRNA expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5250924">
<property type="pathway name" value="B-WICH complex positively regulates rRNA expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5334118">
<property type="pathway name" value="DNA methylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5578749">
<property type="pathway name" value="Transcriptional regulation by small RNAs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5617472">
<property type="pathway name" value="Activation of anterior HOX genes in hindbrain development during early embryogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5625886">
<property type="pathway name" value="Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693565">
<property type="pathway name" value="Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693571">
<property type="pathway name" value="Nonhomologous End-Joining (NHEJ)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693607">
<property type="pathway name" value="Processing of DNA double-strand break ends"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-606279">
<property type="pathway name" value="Deposition of new CENPA-containing nucleosomes at the centromere"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69473">
<property type="pathway name" value="G2/M DNA damage checkpoint"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73728">
<property type="pathway name" value="RNA Polymerase I Promoter Opening"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73772">
<property type="pathway name" value="RNA Polymerase I Promoter Escape"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866654">
<property type="pathway name" value="E3 ubiquitin ligases ubiquitinate target proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8936459">
<property type="pathway name" value="RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939236">
<property type="pathway name" value="RUNX1 regulates transcription of genes involved in differentiation of HSCs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9018519">
<property type="pathway name" value="Estrogen-dependent gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912446">
<property type="pathway name" value="Meiotic recombination"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9609690">
<property type="pathway name" value="HCMV Early Events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9610379">
<property type="pathway name" value="HCMV Late Events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9616222">
<property type="pathway name" value="Transcriptional regulation of granulopoiesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9670095">
<property type="pathway name" value="Inhibition of DNA recombination at telomere"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-977225">
<property type="pathway name" value="Amyloid fiber formation"/>
</dbReference>
<dbReference type="SIGNOR" id="P33778"/>
<dbReference type="BioGRID-ORCS" id="3018">
<property type="hits" value="501 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="HIST1H2BB">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="HIST1H2BB"/>
<dbReference type="GenomeRNAi" id="3018"/>
<dbReference type="Pharos" id="P33778">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P33778"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 6"/>
</dbReference>
<dbReference type="RNAct" id="P33778">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000276410">
<property type="expression patterns" value="Expressed in stomach and 99 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="P33778">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000784">
<property type="term" value="C:nuclear chromosome, telomeric region"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000786">
<property type="term" value="C:nucleosome"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0006334">
<property type="term" value="P:nucleosome assembly"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.20.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR009072">
<property type="entry name" value="Histone-fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR007125">
<property type="entry name" value="Histone_H2A/H2B/H3"/>
</dbReference>
<dbReference type="InterPro" id="IPR000558">
<property type="entry name" value="Histone_H2B"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR23428">
<property type="entry name" value="PTHR23428"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00125">
<property type="entry name" value="Histone"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00621">
<property type="entry name" value="HISTONEH2B"/>
</dbReference>
<dbReference type="SMART" id="SM00427">
<property type="entry name" value="H2B"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47113">
<property type="entry name" value="SSF47113"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00357">
<property type="entry name" value="HISTONE_H2B"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0379">Hydroxylation</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0544">Nucleosome core</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="4">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Histone H2B type 1-B" id="PRO_0000071832">
<location>
<begin position="2"/>
<end position="126"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylproline" evidence="4">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="N6-(2-hydroxyisobutyryl)lysine; alternate" evidence="19">
<location>
<position position="6"/>
</location>
</feature>
<feature type="modified residue" description="N6-(beta-hydroxybutyryl)lysine; alternate" evidence="21">
<location>
<position position="6"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="13">
<location>
<position position="6"/>
</location>
</feature>
<feature type="modified residue" description="N6-butyryllysine; alternate" evidence="20">
<location>
<position position="6"/>
</location>
</feature>
<feature type="modified residue" description="N6-crotonyllysine; alternate" evidence="17">
<location>
<position position="6"/>
</location>
</feature>
<feature type="modified residue" description="N6-(beta-hydroxybutyryl)lysine; alternate" evidence="21">
<location>
<position position="12"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="9">
<location>
<position position="12"/>
</location>
</feature>
<feature type="modified residue" description="N6-crotonyllysine; alternate" evidence="17">
<location>
<position position="12"/>
</location>
</feature>
<feature type="modified residue" description="N6-(2-hydroxyisobutyryl)lysine; alternate" evidence="19">
<location>
<position position="13"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="3 13">
<location>
<position position="13"/>
</location>
</feature>
<feature type="modified residue" description="N6-crotonyllysine; alternate" evidence="17">
<location>
<position position="13"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by STK4/MST1" evidence="12">
<location>
<position position="15"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="3 13">
<location>
<position position="16"/>
</location>
</feature>
<feature type="modified residue" description="N6-crotonyllysine; alternate" evidence="17">
<location>
<position position="16"/>
</location>
</feature>
<feature type="modified residue" description="N6-(beta-hydroxybutyryl)lysine; alternate" evidence="21">
<location>
<position position="17"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="3">
<location>
<position position="17"/>
</location>
</feature>
<feature type="modified residue" description="N6-crotonyllysine; alternate" evidence="17">
<location>
<position position="17"/>
</location>
</feature>
<feature type="modified residue" description="N6-glutaryllysine; alternate" evidence="22">
<location>
<position position="17"/>
</location>
</feature>
<feature type="modified residue" description="N6-(2-hydroxyisobutyryl)lysine; alternate" evidence="19">
<location>
<position position="21"/>
</location>
</feature>
<feature type="modified residue" description="N6-(beta-hydroxybutyryl)lysine; alternate" evidence="21">
<location>
<position position="21"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="3 13">
<location>
<position position="21"/>
</location>
</feature>
<feature type="modified residue" description="N6-butyryllysine; alternate" evidence="20">
<location>
<position position="21"/>
</location>
</feature>
<feature type="modified residue" description="N6-crotonyllysine; alternate" evidence="17">
<location>
<position position="21"/>
</location>
</feature>
<feature type="modified residue" description="N6-(2-hydroxyisobutyryl)lysine; alternate" evidence="19">
<location>
<position position="24"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="3">
<location>
<position position="24"/>
</location>
</feature>
<feature type="modified residue" description="N6-crotonyllysine; alternate" evidence="17">
<location>
<position position="24"/>
</location>
</feature>
<feature type="modified residue" description="N6-(2-hydroxyisobutyryl)lysine" evidence="19">
<location>
<position position="25"/>
</location>
</feature>
<feature type="modified residue" description="N6-(2-hydroxyisobutyryl)lysine; alternate" evidence="19">
<location>
<position position="35"/>
</location>
</feature>
<feature type="modified residue" description="N6-(beta-hydroxybutyryl)lysine; alternate" evidence="21">
<location>
<position position="35"/>
</location>
</feature>
<feature type="modified residue" description="N6-crotonyllysine; alternate" evidence="17">
<location>
<position position="35"/>
</location>
</feature>
<feature type="modified residue" description="N6-glutaryllysine; alternate" evidence="22">
<location>
<position position="35"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="18">
<location>
<position position="35"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by AMPK" evidence="9">
<location>
<position position="37"/>
</location>
</feature>
<feature type="modified residue" description="N6-(2-hydroxyisobutyryl)lysine; alternate" evidence="19">
<location>
<position position="44"/>
</location>
</feature>
<feature type="modified residue" description="N6-glutaryllysine; alternate" evidence="22">
<location>
<position position="44"/>
</location>
</feature>
<feature type="modified residue" description="N6-(2-hydroxyisobutyryl)lysine; alternate" evidence="19">
<location>
<position position="47"/>
</location>
</feature>
<feature type="modified residue" description="N6-glutaryllysine; alternate" evidence="22">
<location>
<position position="47"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine; alternate" evidence="6">
<location>
<position position="47"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="6">
<location>
<position position="58"/>
</location>
</feature>
<feature type="modified residue" description="N6-(2-hydroxyisobutyryl)lysine; alternate" evidence="19">
<location>
<position position="58"/>
</location>
</feature>
<feature type="modified residue" description="Dimethylated arginine" evidence="10">
<location>
<position position="80"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6,N6-trimethyllysine; alternate" evidence="10">
<location>
<position position="86"/>
</location>
</feature>
<feature type="modified residue" description="N6-(2-hydroxyisobutyryl)lysine; alternate" evidence="19">
<location>
<position position="86"/>
</location>
</feature>
<feature type="modified residue" description="N6-(beta-hydroxybutyryl)lysine; alternate" evidence="21">
<location>
<position position="86"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="10">
<location>
<position position="86"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="10">
<location>
<position position="87"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="10">
<location>
<position position="93"/>
</location>
</feature>
<feature type="modified residue" description="N6-(2-hydroxyisobutyryl)lysine; alternate" evidence="19">
<location>
<position position="109"/>
</location>
</feature>
<feature type="modified residue" description="N6-glutaryllysine; alternate" evidence="22">
<location>
<position position="109"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine; alternate" evidence="6">
<location>
<position position="109"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7">
<location>
<position position="116"/>
</location>
</feature>
<feature type="modified residue" description="N6-(2-hydroxyisobutyryl)lysine; alternate" evidence="19">
<location>
<position position="117"/>
</location>
</feature>
<feature type="modified residue" description="N6-(beta-hydroxybutyryl)lysine; alternate" evidence="21">
<location>
<position position="117"/>
</location>
</feature>
<feature type="modified residue" description="N6-glutaryllysine; alternate" evidence="22">
<location>
<position position="117"/>
</location>
</feature>
<feature type="modified residue" description="N6-malonyllysine; alternate" evidence="18">
<location>
<position position="117"/>
</location>
</feature>
<feature type="modified residue" description="N6-methylated lysine; alternate" evidence="7">
<location>
<position position="117"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="18">
<location>
<position position="117"/>
</location>
</feature>
<feature type="modified residue" description="N6-(2-hydroxyisobutyryl)lysine; alternate" evidence="19">
<location>
<position position="121"/>
</location>
</feature>
<feature type="modified residue" description="N6-(beta-hydroxybutyryl)lysine; alternate" evidence="21">
<location>
<position position="121"/>
</location>
</feature>
<feature type="modified residue" description="N6-glutaryllysine; alternate" evidence="22">
<location>
<position position="121"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="18">
<location>
<position position="121"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) serine" evidence="6">
<location>
<position position="113"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="5">
<location>
<position position="6"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="8">
<location>
<position position="21"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="16">
<location>
<position position="35"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate" evidence="14 15">
<location>
<position position="121"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="39"/>
<end position="49"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="57"/>
<end position="84"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="88"/>
<end position="90"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="92"/>
<end position="102"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="105"/>
<end position="123"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3X1S"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3X1U"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P23527"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P58876"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P62807"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q00729"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q5QNW6"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q64475"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q96A08"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11709551"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12757711"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16283522"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16307923"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16713563"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21726816"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21925322"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22389435"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24681537"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27105113"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27105115"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31542297"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000305"/>
<evidence key="24" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:4751"/>
</source>
</evidence>
<sequence length="126" mass="13950" checksum="D2D6B95A9A344EF7" modified="2007-01-23" version="2">MPEPSKSAPAPKKGSKKAITKAQKKDGKKRKRSRKESYSIYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

